Study on the Diagnostic Value of Serum Markers in the Natural History of Chronic HBV Infection
Yu Wenjun1, Yu Tingting2, Li Lihua2, Wang Hongying2, Pu Dong2*
(1. College of Public Health, Dali University, Dali, Yunnan 671000, China; 2 Department of Laboratory, Kunming Third People′s
Hospital, Kunming 650041, China)
Yu Wenjun, Yu Tingting, Li Lihua, Wang Hongying, Pu Dong. Study on the Diagnostic Value of Serum Markers in the Natural History of Chronic HBV Infection[J]. Journal of Dali University, 2025, 10(2): 67-74.
〔1〕 FRANCO E,PETTINICCHIO V,ZORZOLI E. The Evolution
of the Burden of Viral Hepatitis from 1990 to 2013:
Still an Open Challenge to Global Public Health Policy〔J〕.
Hepatobiliary Surg Nutr,2017,6(4):277-279.
〔2〕 吴晓宁,尤红,贾继东. 迈向再无病毒性肝炎威胁的
2030〔J〕. 肝脏,2023,28(1):28-30.
〔3〕 中华医学会肝病学分会,中华医学会感染病学分会. 慢
性乙型肝炎防治指南(2022年版)〔J〕. 实用肝脏病杂志,
2023,26(3):S18-S32.
〔4〕 TERRAULT N A,LOK A S F,MCMAHON B J,et al.
Update on Prevention,Diagnosis,and Treatment of Chronic
Hepatitis B:AASLD 2018 Hepatitis B Guidance〔J〕. Hepatology,
2018,67(4):1560-1599.
〔5〕 LEMOINE M,SHIMAKAWA Y,NAYAGAM S,et al. The
Gamma-Glutamyl Transpeptidase to Platelet Ratio (GPR)
Predicts Significant Liver Fibrosis and Cirrhosis in Patients
with Chronic HBV Infection in West Africa〔J〕. Gut,2016,
65(8):1369-1376.
〔6〕 MARTIN P,LAU D T,NGUYEN M H,et al. A Treatment
Algorithm for the Management of Chronic Hepatitis B Virus
Infection in the United States:2015 Update〔J〕. Clin Gastroenterol
Hepatol,2015,13(12):2071-2087.
〔7〕 ZOULIM F,LEBOSSÉ F,LEVRERO M. Current Treatments
for Chronic Hepatitis B Virus Infections〔J〕. Curr
Opin Virol,2016,18:109-116.
〔8〕 陈武镇. 超声引导下肝脏穿刺活检并发症分析与研
究〔J〕. 现代医用影像学,2017,26(6):1774-1775.
〔9〕 LI M R,XU Z G,LU J H,et al. Clinical Features of Hepatitis
B Patients at Immune-Tolerance Phase with Basal Core
Promoter and/or Precore Mutations〔J〕. J Viral Hepat,
2020,27(10):1044-1051.
〔10〕 朱霞,唐红. HBsAg定量与HBV DNA载量在HBV感染
自然史不同阶段的临床意义〔J〕. 四川大学学报(医学
版),2019,50(5):771-774.
〔11〕 高鹏,肖萍,陈青锋,等. 影响慢性乙型肝炎后重症肝炎
患者红细胞系统参数的因素及其探讨〔C〕//第6届全国
疑难及重症肝病大会论文集. 2011:145-146.
〔12〕 贺铮铮,孙俊,王莉,等. AIDS患者肝损伤的外周血指
标相关性分析〔J〕. 大理大学学报,2021,6(10):67-71.
〔13〕 WANG L,ZOU Z Q,WANG K,et al. Role of Serum
Hepatitis B Virus Marker Quantitation to Differentiate
Natural History Phases of HBV Infection〔J〕. Hepatol Int,
2016,10(1):133-138.
〔14〕 薛占成,韩海燕,周秀. HBsAg和HBV DNA定量水平在
慢性HBV感染自然史中的变化〔J〕. 黑龙江医学,2023,
47(12):1413-1415.
〔15〕 王娟霞,陈馨悦,魏世博,等. 慢性乙型肝炎患者肝脏炎
症程度预测模型的研究〔J〕. 中国实用内科杂志,2023,
43(5):390-395.
〔16〕 姚秋艳,吴泽生,施荣杰,等. 酒精性肝病相关慢加急性
肝衰竭短期预后的影响因素分析〔J〕. 大理大学学报,
2023,8(2):36-41.
〔17〕 武抗抗,杨晨辰,黄睿,等. 慢性乙型肝炎患者不同免疫
状态下血清γ 谷氨酰转肽酶水平变化及其临床意
义〔J〕. 实用医学杂志,2014,30(13):2068-2071.
〔18〕 何静,王保龙,赵亮,等. 血清AFP、GP73水平检测对非
肝癌慢性HBV 感染者的临床价值〔J〕. 检验医学与临
床,2020,17(14):2027-2029.
〔19〕 庞晓鹰,徐洪涛,杨秀珍,等. 慢性乙型肝炎免疫清除期
甲胎蛋白与HBV DNA清除的相关性研究〔J〕. 中华实
验和临床感染病杂志(电子版),2014,8(2):223-226.
〔20〕 周新兰,马鑫,王雁冰,等. APRI、FIB-4和GPR对慢性
乙型肝炎肝脏炎症程度的诊断价值〔J〕. 临床肝胆病杂
志,2021,37(9):2066-2070.
〔21〕 严美红. APRI、FIB-4、RPR和GPR在慢性HBV感染病
程诊断中的意义〔D〕. 青岛:青岛大学,2021.
〔22〕 WANG J,SHEN T,HUANG X B,et al. Serum Hepatitis
B Virus RNA Is Encapsidated Pregenome RNA That May
Be Associated with Persistence of Viral Infection and
Rebound〔 J〕. J Hepatol,2016,65(4):700-710.
〔23〕 YUEN M F,CHEN D S,DUSHEIKO G M,et al. Hepatitis
B Virus Infection〔J〕. Nat Rev Dis Primers,2018,4:
18035.
〔24〕 LIU Y Y,JIANG M,XUE J Y,et al. Serum HBV RNA
Quantification:Useful for Monitoring Natural History of
Chronic Hepatitis B Infection〔J〕. BMC Gastroenterol,
2019,19(1):53.
〔25〕 ESMAEELZADEH A,SAADATNIA H,MEMAR B,et al.
Evaluation of Serum HBV Viral Load,Transaminases and
Histological Features in Chronic HBeAg-Negative Hepatitis
B Patients〔J〕. Gastroenterol Hepatol Bed Bench,
2017,10(1):39-43.
〔26〕 刘卫平,许德军,赵连荣,等. 慢性乙型肝炎肝纤维化无
创检测模型建立及应用价值验证〔J〕. 中华内科杂志,
2008,47(4):308-312.
〔27〕 CHENG J L,WANG X L,YANG S G,et al. Non-ALT
Biomarkers for Markedly Abnormal Liver Histology among
Chinese Persistently Normal Alanine Aminotransferase-
Chronic Hepatitis B Patients〔J〕. World J Gastroenterol,
2017,23(15):2802-2810.
〔28〕 刘勇. 肝硬化患者中生化检验项目的应用进展〔J〕.
内蒙古中医药,2016,35(7):127-128.